Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has filed a complaint with the US District Court for the Eastern District of New York seeking an injunction to stop Kabco Pharmaceuticals and owner Abu Kabir from producing and distributing dietary supplements.
Subscribe to our email newsletter
The move follows the agency’s warning to the company over the repeated violations of cGMPs (current good manufacturing practices) and the Federal Food, Drug and Cosmetic Act.
In 2010, FDA inspection found that Kabco distributed supplements that did not meet product specifications.
The company also failed to investigate product complaints and hold dietary supplements under conditions designed to prevent product mix-ups, according to the agency.
FDA wants Kabco to comply with the Federal Food, Drug and Cosmetic Act and cGMPs before the company restarts its operations.
Kabco Pharmaceuticals dietary supplements include Brewers Yeast Tablets, Dandelion Root Capsules and Night-Time Herb Capsules.
The other products include Inositol Calcium and Magnesium Capsules, Vitamin C-500 with Rose Hips Time Released Tablets and Joint All Capsules.